(1)
An Overview of Epidermodysplasia Verruciformis. Int. J. of Res. in Pharmacology &Pharmacotherapeutics 2022, 11 (2), 76-84. https://doi.org/10.61096/ijrpp.v11.iss2.2022.76-84.